| North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies UA Shah, EY Chung, O Giricz, K Pradhan, K Kataoka, S Gordon-Mitchell, ... Blood, The Journal of the American Society of Hematology 132 (14), 1507-1518, 2018 | 82 | 2018 |
| An oxidative stress-based mechanism of doxorubicin cytotoxicity suggests new therapeutic strategies in ABC-DLBCL Y Mai, JJ Yu, B Bartholdy, ZY Xu-Monette, EE Knapp, F Yuan, H Chen, ... Blood, The Journal of the American Society of Hematology 128 (24), 2797-2807, 2016 | 54 | 2016 |
| PAK kinase inhibition has therapeutic activity in novel preclinical models of adult T-cell leukemia/lymphoma EY Chung, Y Mai, UA Shah, Y Wei, E Ishida, K Kataoka, X Ren, ... Clinical Cancer Research 25 (12), 3589-3601, 2019 | 24 | 2019 |
| A Bach2 link between pre-B cell receptor checkpoint and pre-B cell ALL BH Ye, Y Mai Cancer Cell 24 (3), 282-284, 2013 | 9 | 2013 |
| Expression of IMP1 enhances production of murine leukemia virus vector by facilitating viral genomic RNA packaging Y Mai, G Gao PLoS One 5 (12), 2010 | 5 | 2010 |
| Detecting Ground Glass Opacity Features in Patients With Lung Cancer: Automated Extraction and Longitudinal Analysis via Deep Learning–Based Natural Language Processing K Lee, Z Liu, U Chandran, I Kalsekar, B Laxmanan, MK Higashi, T Jun, ... JMIR AI 2 (1), e44537, 2023 | 4 | 2023 |
| Optimizing Clinical Trial Eligibility Design Using Natural Language Processing Models and Real-World Data: Algorithm Development and Validation K Lee, Z Liu, Y Mai, T Jun, M Ma, T Wang, L Ai, E Calay, W Oh, ... JMIR AI 3, e50800, 2024 | 2 | 2024 |
| A tumor-suppressive role of the IL-21R/Jak/STAT3 pathway in the germinal center B cell subtype of diffuse large B cell lymphomas. BH Ye, E Bi, JJ Yu, Y Mai, BB Ding, Y Yu, A Verma, R Shaknovich, ... Cancer Research 73 (8_Supplement), 3041-3041, 2013 | 2 | 2013 |
| Establishing the Automatic Identification of Clinical Trial Cohorts from Electronic Health Records by Matching Normalized Eligibility Criteria and Patient Clinical Characteristics K Lee, Y Mai, Z Liu, K Raja, MK Higashi, T Jun, M Ma, T Wang, L Ai, ... medRxiv, 2024.02. 28.24303396, 2024 | 1 | 2024 |
| Analyzing treatment patterns and time to the next treatment in chronic lymphocytic leukemia real-world data using automated temporal phenotyping. K Lee, Z Liu, M Ma, Y Mai, C Gilman, M Li, M Zhang, T Mullaney, Q Pan, ... Journal of Clinical Oncology 39 (15_suppl), e19512-e19512, 2021 | 1 | 2021 |
| Automated Extraction and Longitudinal Analysis of Ground Glass OpacityFeatures in Lung Cancer Patients Powered by Natural Language Processing K Lee, Z Liu, M Ma, U Chandran, I Kalsekar, B Laxmanan, M Li, Y Mai, ... D20. NOT YOUR GRANDFATHER'S CT SCAN: RADIOMICS AND DEEP MACHINE LEARNING FOR …, 2022 | | 2022 |
| Inhibiting The xCT Antiporter Sensitizes High Risk DLBCL to Doxorubicin-Containing Therapy X Wei, Y Wei, J Song, Y Mai, F Yuan, J Zhang, R Feng, BH Ye | | 2021 |
| Extracting longitudinal anticancer treatments at scale using deep natural language processing and temporal reasoning. M Ma, K Lee, Y Mai, C Gilman, Z Liu, M Zhang, M Li, A Redfern, ... Journal of Clinical Oncology 39 (15_suppl), e18747-e18747, 2021 | | 2021 |
| Phenotyping of clinical trial eligibility text from cancer studies into computable criteria in electronic health records. Y Mai, K Lee, Z Liu, M Ma, C Gilman, M Li, M Zhang, Z Li, M Fink, ... Journal of Clinical Oncology 39 (15_suppl), 6592-6592, 2021 | | 2021 |
| Automated abstraction of real-world clinical outcome in lung cancer: A natural language processing and artificial intelligence approach from electronic health records. M Ma, A Redfern, X Zhou, D Li, Y Ru, K Lee, C Gilman, Z Liu, S Jones, ... Journal of Clinical Oncology 38 (15_suppl), e14062-e14062, 2020 | | 2020 |
| Representing cancer clinical trial criteria and attributes using ontologies: An NLP-assisted approach. K Lee, Z Liu, M Ma, C Gilman, Y Mai, X Zhou, K Ghosh, R Chen, E Schadt, ... Journal of Clinical Oncology 38 (15_suppl), e14079-e14079, 2020 | | 2020 |
| Phenotyping clinical trial treatment regimens in cancer: An integrative ontology, artificial intelligence and knowledge engineering approach. Y Mai, K Lee, Z Liu, Z Li, S Jones, M Ma, M Fink, K Ghosh, R Chen, ... Journal of Clinical Oncology 38 (15_suppl), e14054-e14054, 2020 | | 2020 |
| DxTree: a visual analytics tool for hierarchical representation of disease cohort counts for clinical trials. M Zhang, Z Liu, M Ma, K Lee, Y Mai, S Jones, C Gilman, Y Ru, M Deitz, ... AMIA, 2020 | | 2020 |
| North American Adult T Cell Leukemia Lymphoma (ATLL) Is Characterized By Distinct, Therapeutically Targetable Mutations in Epigenetic Modifiers UA Shah, Y Wang, O Giricz, S Gordon, TD Bhagat, Y Mai, Y Wei, N Gitego, ... Blood 130, 1455, 2017 | | 2017 |
| The xCT Antiporter Is a Therapeutic Target in the ABC Subtype of DLBCL X Wei, Y Mai, R Feng, BH Ye Blood 126 (23), 3996, 2015 | | 2015 |